Limazocic
Alternative Names: SA 3443Latest Information Update: 15 Nov 1995
Price :
$50 *
At a glance
- Originator Santen Pharmaceutical
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver disorders
Most Recent Events
- 15 Nov 1995 Discontinued-II for Liver disorders in Japan (Unknown route)